SCHEMBL9788371

SCHEMBL9788371

Nc1ccc(OC(=O)c2ccc3cc(C(=O)Oc4ccc(N)cc4)ccc3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.58
PRSS1 P07477 4/20 0.58
PRSS2 P07478 3/20 0.58
PRSS3 P35030 3/20 0.58
KMT2A Q03164 2/20 0.58
PKM P14618 1/20 0.58
NR1H4 Q96RI1 1/20 0.53
HGFAC Q04756 3/20 0.49
MAPT P10636 3/20 0.49
PARP10 Q53GL7 2/20 0.49
MEN1 O00255 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
LMNA P02545 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
CHRM1 P11229 2/20 0.47
ADRA1A P35348 2/20 0.47
SLC6A3 Q01959 2/20 0.47
TMPRSS2 O15393 1/20 0.47
MLNR O43193 1/20 0.47
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9788373 0.93 KDM4E (0.53) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL11649516 0.93 KMT2A (0.60) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL347429 0.88 PRSS1 (0.71) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL346698 0.88 PRSS1 (0.71) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL107649 0.88 PRSS1 (0.71) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL4132832 0.87 KMT2A (0.57) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL13292773 0.85 KMT2A (0.64) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL8445592 0.85 KMT2A (0.54) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL6052916 0.84 KMT2A (0.58) F2PRSS1PRSS2PRSS3KMT2A
SCHEMBL12268693 0.84 HGFAC (0.50) F2PRSS1PRSS2PRSS3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3279350-A None JP disclosed
US-20130203895-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-08-08 US disclosed
US-20130203895-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-08-08 US disclosed
US-20130012620-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-01-10 US disclosed
US-20130012620-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2013-01-10 US disclosed
US-8288591-B2 Curing agents for epoxy resins DESIGNER MOLECULES, INC. (US) 2012-10-16 US disclosed
US-8288591-B2 Curing agents for epoxy resins DESIGNER MOLECULES, INC. (US) 2012-10-16 US disclosed
US-20100144977-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2010-06-10 US disclosed
US-20100144977-A1 CURING AGENTS FOR EPOXY RESINS DESIGNER MOLECULES, INC. (US) 2010-06-10 US disclosed
JP-H03279350-A DIAMINE DERIVATIVE HAVING NAPHTHALENE SKELETON NIPPON STEEL CHEM CO LTD 1991-12-10 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012620-A1 CURING AGENTS FOR EPOXY RESINS DOT1L, EHMT1, ASH1L F2 1820/4885PRSS1 3472/4885PRSS2 3109/4885
US-20100144977-A1 CURING AGENTS FOR EPOXY RESINS PTGER3, PTGER4, ELL F2 727/4885PRSS1 3579/4885PRSS2 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.